262 related articles for article (PubMed ID: 24933152)
1. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
[TBL] [Abstract][Full Text] [Related]
2. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
4. Expression of SMARCB1 (INI1) mutations in familial schwannomatosis.
Smith MJ; Walker JA; Shen Y; Stemmer-Rachamimov A; Gusella JF; Plotkin SR
Hum Mol Genet; 2012 Dec; 21(24):5239-45. PubMed ID: 22949514
[TBL] [Abstract][Full Text] [Related]
5. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
Plotkin SR; Blakeley JO; Evans DG; Hanemann CO; Hulsebos TJ; Hunter-Schaedle K; Kalpana GV; Korf B; Messiaen L; Papi L; Ratner N; Sherman LS; Smith MJ; Stemmer-Rachamimov AO; Vitte J; Giovannini M
Am J Med Genet A; 2013 Mar; 161A(3):405-16. PubMed ID: 23401320
[TBL] [Abstract][Full Text] [Related]
6. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
[TBL] [Abstract][Full Text] [Related]
7. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
[TBL] [Abstract][Full Text] [Related]
8. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1.
Swensen JJ; Keyser J; Coffin CM; Biegel JA; Viskochil DH; Williams MS
J Med Genet; 2009 Jan; 46(1):68-72. PubMed ID: 19124645
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
[TBL] [Abstract][Full Text] [Related]
10. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
11. An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.
Toms J; Harrison J; Richard H; Childers A; Reiter ER; Graham RS
J Neurosurg Spine; 2016 Jan; 24(1):160-6. PubMed ID: 26431068
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
[TBL] [Abstract][Full Text] [Related]
13. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract][Full Text] [Related]
14. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline
Lee JH; Jeong JS; Chae KJ; Han YH; Kim SR; Lee YC
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363549
[TBL] [Abstract][Full Text] [Related]
19. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
[TBL] [Abstract][Full Text] [Related]
20. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]